Modulations of cytochrome P450 expression in diabetic mice by berberine

Chemico-Biological Interactions

Volumn 196, Issue 1-2, 2012, Pages 23-29

  Chatuphonprasert, Waranya ^a   Nemoto, Nobuo ^b   Sakuma, Tsutomu ^b   Jarukamjorn, Kanokwan ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

^b UNIVERSITY OF TOYAMA   (Japan)

Author keywords

Berberine; Cytochrome P450; Diabetic mice; Mouse hepatocytes; Streptozotocin

Indexed keywords

BERBERINE; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2B10; CYTOCHROME P450 2B9; CYTOCHROME P450 2E1; CYTOCHROME P450 3A11; CYTOCHROME P450 4A10; CYTOCHROME P450 4A14; MESSENGER RNA; METFORMIN; STREPTOZOCIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INDUCTION; ENZYME INHIBITION; LIVER CELL; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; STREPTOZOCIN DIABETES;

ANIMALS; BERBERINE; BLOOD GLUCOSE; CYTOCHROME P-450 ENZYME SYSTEM; DIABETES MELLITUS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEPATOCYTES; LIVER; MALE; MICE; RANDOM ALLOCATION; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER;

BERBERIS ARISTATA; COPTIS; COPTIS JAPONICA; HYDRASTIS CANADENSIS; MUS;

EID: 84857491750     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2012.01.006     Document Type: Article

References (37)

1. S. Wild, G. Roglic, A. Green, R. Sicree, H. King, Global prevalence of diabetes: estimates for the year 2000 and projections for 2030, Diabetes Care 27 (2004) 1047-1053. (Pubitemid 38579764)
2. H. King, R.E. Aubert, and W.H. Herman Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections Diabetes Care 21 1998 1414 1431 (Pubitemid 28405191)
3. N. Shimojo, T. Ishizaki, S. Imaoka, Y. Funae, S. Fuji, and K. Okuda Changes in amounts of cytochrome P450 isozymes and levels of catalytic activities in hepatic and renal microsomes of rats with streptozocin-induced diabetes Biochem. Pharmacol. 46 1993 621 627 (Pubitemid 23262955)
4. Z. Wang, S.D. Hall, J.F. Maya, L. Li, A. Asghar, and J.C. Gorski Diabetes mellitus increases the in vivo activity of cytochrome P450 2E1 in humans Br. J. Clin. Pharmacol. 55 2003 77 85 (Pubitemid 36110842)
5. T. Sakuma, R. Honnia, S. Maguchi, H. Tamaki, and N. Nemoto Different expression of hepatic and renal cytochrome P450s between the streptozotocin induced diabetic mouse and rat Xenobiotica 31 2001 223 237 (Pubitemid 32651749)
6. C.R. Barnett, P.R. Flatt, and C. Ioannides Induction of hepatic microsomal P450 I and IIB protein by heperketonemia Biochem. Pharmacol. 40 1990 393 397 (Pubitemid 20218863)
7. S. Kimura, J.P. Hardwick, C.A. Kozak, and F.J. Gonzalez The rat clofibrate-inducible CYP4A subfamily II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes DNA 8 1989 517 525 (Pubitemid 19235721)
8. C. Delescluse, G. Lemaire, G. de Sousa, and R. Rahmani Is CYP1A1 induction always related to AHR signaling pathway? Toxicology 153 2000 73 82
9. F.P. Guengerich Cytochrome P450 and chemical toxicology Chem. Res. Toxicol. 21 2008 70 83 (Pubitemid 351219709)
10. P. Rojsanga, W. Gritsanapan, and L. Suntornsuk Determination of berberine content in the stem extracts of Coscinium fenestratum by densitometry Med. Princ. Pract. 15 2006 373 378 (Pubitemid 44186826)
11. Y. Zhang, X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, G. Ren, and G. Ning Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine J. Clin. Endocrinol. Metab. 93 2008 2559 2565 (Pubitemid 352008520)
12. Q. Zhang, X. Xiao, K. Feng, T. Wang, W. Li, T. Yuan, X. Sun, Q. Sun, H. Xiang, and H. Wang Berberine moderates glucose and lipid metabolism through multi pathway mechanism Evid. Based Complement. Alternat. Med. 2011 2011 1 10
13. P. Chatterjee, and M.R. Franklin Human cytochrome P450 inhibition and metabolic-intermediate complex formation by goldenseal extract and its methylenedioxyphenyl components Drug Metab. Dispos. 31 2003 1391 1397 (Pubitemid 37310329)
14. B.J. Gurley, A. Swain, M.A. Hubbard, F. Hartsfield, J. Thaden, D.K. Williams, W.B. Gentry, and Y. Tong Supplementation with goldenseal (Hydrastis canadensis), but not kava kava (Piper methysticum), inhibits human CYP3A activity in vivo Clin. Pharmacol. Ther. 83 2008 61 69
15. Y. Zhao, B.H. Hellum, A. Liang, and O.G. Nilsen The in vitro inhibition of human CYP1A2, CYP2D6 and CYP3A4 by tetrahydropalmatine, neferine and berberine Phytother. Res. 2011 10.1002/ptr.3554
16. W. Chatuphonprasert, T. Sangkawat, N. Nemoto, and K. Jarukamjorn Suppression of beta-naphthoflavone induced CYP1A expression and lipid-peroxidation by berberine Fitoterapia 82 2011 889 895
17. N. Nemoto, and J. Sakurai Glucocorticoid and sex hormones as activating or modulating factors for expression of Cyp2b-9 and Cyp2b-10 in the mouse liver and hepatocytes Arch. Biochem. Biophys. 319 1995 286 292
18. K. Jarukamjorn, T. Sakuma, J. Miyaura, and N. Nemoto Different regulation of the expression of mouse hepatic cytochrome P450 2B enzymes by glucocorticoid and phenobarbital Arch. Biochem. Biophys. 369 1999 89 99 (Pubitemid 29434541)
19. K. Hayashi, R. Kojima, and M. Ito Strain differences in the diabetogenic activity of streptozotocin in mice Biol. Pharm. Bull. 29 2006 1110 1119 (Pubitemid 43845468)
20. K. Srinivasan, and P. Ramarao Animal models in type 2 diabetes research: an overview Indian J. Med. Res. 125 2007 451 472 (Pubitemid 46805458)
21. W. Chatuphonprasert, K. Jarukamjorn, S. Kondo, and N. Nemoto Synergistic increases of metabolism and oxidation-reduction genes on their expression after combined treatment with a CYP1A inducer and andrographolide Chem.-Biol. Interact. 182 2009 233 238
22. C. Hassett, E.M. Laurenzana, J.S. Sidhu, and C.J. Omiecinski Effects of chemical inducers on human microsomal epoxide hydrolase in primary hepatocyte cultures Biochem. Pharmacol. 55 1998 1059 1069 (Pubitemid 28167727)
23. B.G. Lake, A.B. Renwick, M.E. Cunninghame, R.J. Price, D. Surry, and D.C. Evans Comparison of the effects of some CYP3A and other enzyme inducers on replicative DNA synthesis and cytochrome P450 isoforms in rat liver Toxicology 131 1998 9 20 (Pubitemid 28540733)
24. X. Cui, H. Kawashima, T.B. Barclay, J.M. Peters, F.J. Gonzalez, E.T. Morgan, and H.W. Strobel Molecular cloning and regulation of expression of two novel mouse CYP4F genes: expression in peroxisome proliferator-activated receptor α-deficient mice upon lipopolysaccharide and clofibrate challenges J. Pharmacol. Exp. Therapeut. 296 2001 542 550 (Pubitemid 32112484)
25. Y. Guo, C. Pope, X. Cheng, H. Zhoua, and C.D. Klaassen Dose-response of berberine on hepatic cytochromes P450 mRNA expression and activities in mice J. Ethnopharmacol. 138 2011 111 118
26. X. Zhao, J. Zhang, X. Wang, X. Bu, Y. Lou, and G. Zhang Effect of berberine on hepatocyte proliferation, inducible nitric oxide synthase expression, cytochrome P450 2E1 and 1A2 activities in diethylnitrosamine- and phenobarbital-treated rats Biomed. Pharmacother. 62 2008 567 572
27. W. Qiu, X.H. Jiang, C.X. Liu, Y. Ju, and J.X. Jin Effect of berberine on the pharmacokinetics of substrates of CYP3A and P-gp Phytother. Res. 23 2009 1553 1558
28. C. Zhou, X. Li, W. Fang, X. Yang, L. Hu, S. Zhou, and J. Zhou Inhibition of CYP450 1A and 3A by berberine in crucian carp Carassius auratus gibelio Comp. Biochem. Physiol., C 154 2011 360 366
29. A.C. Maritim, R.A. Sanders, and J.B. Watkins Diabetes, oxidative stress, and antioxidants: a review Biochem. Mol. Toxicol. 17 2003 24 38 (Pubitemid 36410972)
30. T. Szkudelski The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas Physiol. Res. 50 2001 536 546
31. B. Soria, E. Roche, G. Berná, T. León-Quinto, J.A. Reig, and F. MartínInsulin Secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice Diabetes 49 2000 157 162 (Pubitemid 30070992)
32. L.Q. Tang, W. Wei, L.M. Chen, and S. Liu Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats J. Ethnopharmacol. 108 2006 109 115 (Pubitemid 44498992)
33. K. Shankar, V.S. Vaidya, U.M. Apte, J.E. Manautou, M.J.J. Ronis, T.J. Bucci, and H.M. Mehendale Type 1 diabetic mice are protected from acetaminophen hepatotoxicity Toxicol. Sci. 73 2003 220 234 (Pubitemid 36701729)
34. Y. Yamazoe, N. Murayama, M. Shimada, K. Yamauchi, and R. Kato Cytochrome P450 in livers of diabetic rats: regulation by growth hormone and insulin Arch. Biochem. Biophys. 268 1989 567 575 (Pubitemid 19049735)
35. M.D. Weltman, G.C. Farrell, P. Hall, M. Ingelman-Sundberg, and C. Liddle Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis Hepatology 27 1998 128 133 (Pubitemid 28041545)
36. C.L.K. Koide, A.C. Collier, NM.J. Berry, J. Panee, The effect of bamboo extract on hepatic biotransforming enzymes - findings from an obese-diabetic mouse model, J. Ethnopharmacol. 133 (2011) 37-45.
37. K.E. Thummel, and G.R. Wilkinson In vitro and in vivo drug interactions involving CYP3A Annu. Rev. Pharmacal. Toxicol. 38 1998 389 430 (Pubitemid 28231501)